AI Deals and Investments
  • All Technology
  • AI
  • Autonomy
  • B2B Growth
  • Big Data
  • BioTech
  • ClimateTech
  • Consumer Tech
  • Crypto
  • Cybersecurity
  • DevOps
  • Digital Marketing
  • Ecommerce
  • EdTech
  • Enterprise
  • FinTech
  • GovTech
  • Hardware
  • HealthTech
  • HRTech
  • LegalTech
  • Nanotech
  • PropTech
  • Quantum
  • Robotics
  • SaaS
  • SpaceTech
AllNewsDealsSocialBlogsVideosPodcastsDigests

AI Pulse

EMAIL DIGESTS

Daily

Every morning

Weekly

Sunday recap

NewsDealsSocialBlogsVideosPodcasts
DP Technology Secures $114M Series C to Accelerate AI for Science in China
Series C

DP Technology Secures $114M Series C to Accelerate AI for Science in China

•December 25, 2025
•Dec 25, 2025
0

Participants

DP Technology Co. Ltd.

DP Technology Co. Ltd.

company

Fortune Venture Capital

Fortune Venture Capital

investor

Beijing Pharmaceutical and Health Industry Investment Fund

Beijing Pharmaceutical and Health Industry Investment Fund

investor

Lenovo

Lenovo

investor

Incubator Group

Incubator Group

investor

Oriza Hua

Oriza Hua

investor

Why It Matters

The capital infusion positions DP Technology to become a foundational AI infrastructure provider for scientific research, potentially reshaping R&D efficiency across multiple high‑impact sectors.

Key Takeaways

  • •Raised 800 million yuan ($114 million) Series C funding.
  • •Targets AI for science across batteries, drugs, labs.
  • •Tools used by 1,000+ universities and 150 corporations.
  • •Founder Zhang Linfeng won 2020 ACM Gordon Bell Prize.
  • •Aims to build AI scientists automating scientific discovery.

Pulse Analysis

DP Technology’s latest funding round underscores a broader shift toward AI‑driven research infrastructure in China. While many domestic AI firms chase consumer‑facing applications, DP focuses on the "AI for science" niche, leveraging large language models to streamline complex tasks such as molecular dynamics simulations and laboratory workflow orchestration. By integrating tools like Particle Universe and Uni‑Lab, the company offers a modular stack that can be adopted by academic labs and industry R&D teams alike, accelerating time‑to‑insight in fields ranging from battery chemistry to drug discovery.

The strategic investors—Fortune Venture Capital, Beijing Jingguorui Equity, and several industry‑specific funds—signal confidence in DP’s ability to commercialize scientific AI at scale. Their backing not only provides capital for talent acquisition but also opens channels to key corporate partners such as PetroChina and BYD, facilitating real‑world validation of the platform. This ecosystem approach mirrors global trends where AI platforms become shared services, reducing duplication of effort across research institutions and fostering collaborative breakthroughs.

Looking ahead, DP Technology’s ambition to create "AI scientists" could redefine the R&D paradigm. By automating hypothesis generation, experiment design, and data analysis, these intelligent agents may lower barriers for smaller firms and universities lacking extensive computational resources. If successful, the model could accelerate the pace of scientific discovery, shorten product development cycles, and generate substantial economic value for China’s high‑tech and manufacturing sectors.

Deal Summary

Beijing-based AI startup DP Technology Co. Ltd. announced a $114 million Series C round, raising 800 million yuan to expand its AI-driven scientific research tools. The round was led by Fortune Venture Capital and Beijing Jingguorui Equity Investment Fund, with participation from several other investors. The funding will be used to hire talent and further develop platforms for drug discovery, battery design, and other scientific applications.

0

Comments

Want to join the conversation?

Loading comments...